Post by LEO Pharma

“Europe faces the choice of being a place where innovation is created and implemented or being a secondary market that passively imports it from elsewhere.” That is the clear message from our CEO, Christophe Bourdon, in a new op-ed featured in POLITICO in collaboration with EFPIA - European Federation of Pharmaceutical Industries and Associations. Europe has the talent, science, healthcare infrastructure, patients and market to lead, but leadership will not happen by default. 🌍As the U.S. and China move faster in biotech, AI and clinical research, Europe must do more to create the conditions for innovation to start, grow and stay here, through stronger investment, connected ecosystems, integrated regulation and predictable incentives🤝 The stakes are high. Investing in life sciences is a strategic multiplier, not only for better patient outcomes, but also for competitiveness, societal resilience and future economic growth💡 Now is the moment for decisionmakers and the life science ecosystems to work together to ensure Europe remains a leading home for life sciences innovation🔬 👉Read the full op-ed here: https://lnkd.in/eZkh95P4